|Bid||10.53 x 900|
|Ask||10.54 x 1100|
|Day's range||10.34 - 10.71|
|52-week range||7.99 - 12.55|
|Beta (5Y monthly)||1.35|
|PE ratio (TTM)||15.92|
|Earnings date||04 May 2021 - 10 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||11.00|
Potential Ironwood Pharmaceuticals, Inc. ( NASDAQ:IRWD ) shareholders may wish to note that the Independent Director...
If you're like me, your investment watch list is overflowing with dozens of stocks and price alerts. Let's examine three biotechs trading at lower than average valuations and consider whether they might be worth putting on your watch list. Supernus Pharmaceuticals (NASDAQ: SUPN) makes drugs that treat disorders of the central nervous system, including epilepsy and Parkinson's disease.
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, announced that management will be presenting at the following investor conferences: